SOURCE: Innovative Health Sciences, Inc.

May 21, 2010 14:26 ET

Innovative Health Sciences, Inc. Announces Termination of Discussions

CLEARWATER, FL--(Marketwire - May 21, 2010) -  Innovative Health Sciences, Inc. (PINKSHEETS: IHSN) announced that it has today terminated discussions incident to the April 29, 2010 Letter of Intent, and that by mutual agreement the letter has been withdrawn. Parties were unable to reach mutually agreeable final terms, and all due diligence actions associated with completing that transaction have now ceased.

About Innovative Health Sciences, Inc.

Innovative Health Sciences, Inc. remains focused on its plan of acquiring companies that are leaders in their respective market niches and have the potential for additional upside. Acquired in 2010, Harrington Multi Media Marketing (HM3) is a leading producer of infomercials and short-form direct television spots and developer of Internet-based marketing campaigns and transactional websites. HM3 also offers complete turnkey solutions to launch new consumer products including: assistance with outsourcing products and prototype development; set-up and management of call centers; product fulfillment and customer service; credit card processing; purchasing and management of media outlets, including telephone sales, direct response television (DRTV), and Internet sales. For more information, please visit www.ihs-development.com or call 727-230-1036.

This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the statements made herein.

Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Contact Information

  • Contact:
    Chris Winter
    President
    Innovative Health Sciences, Inc.
    Tel: 727-230-1036